INTERNATIONAL FLAVORS & FRAGRANCES INC
Close on Oct 19, 2026
- Market cap
- $23.38B
- P/E (TTM)
- –
- Dividend yield
- 1.76%
About International Flavors & Fragrances
Industrial Organic Chemicals, SIC 2860
International Flavors & Fragrances Inc. creates and manufactures ingredients and solutions used across food, beverage, health, biosciences, and scent applications. Operating primarily through four segments—Taste, Food Ingredients, Health & Biosciences, and Scent—the company offers flavor compounds, specialty food ingredients like plant-based proteins and natural preservatives, biotechnology-derived enzymes, probiotics, cultures, and fragrance compounds. Its offerings serve consumer-goods manufacturers producing items such as dairy, meats, beverages, snacks, dietary supplements, home cleaning products, personal care items, perfumes, and animal nutrition.
The enterprise maintains a worldwide operational footprint with approximately 170 manufacturing facilities, creative centers, and application laboratories located in about 30 countries, alongside five primary research and development centers in the United States, Denmark, and the Netherlands. The organization employs roughly 21,500 people across the globe, with approximately 5,500 based in the United States. Its principal executive offices are situated in New York, New York, and Wilmington, Delaware.
Summary of the business section of International Flavors & Fragrances's latest annual report, written by StockData.
Company profile
Company
- Legal name
- INTERNATIONAL FLAVORS & FRAGRANCES INC
- Founded
- 1958
- Headquarters
- New York, NY
- Address
- 521 W 57th St 10019
- Phone
- (212) 765-5500
- Website
- iff.com
- Employees
- 21,500, Dec 31, 2025
- Industry
- Industrial Organic Chemicals
- Incorporated in
- New York
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, New York, New York
Stock & identifiers
- Ticker
- IFF
- Exchange
- NYSE
- Shares outstanding
- 255M, Jul 31, 2026
- Public float
- $18.85B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 3-for-1, Jan 20, 1994
- SEC CIK
- 51253
- CUSIP
- 459506101
- ISIN
- US4595061015
- LEI
- BZLRL03D3GPGMOGFO832
- EIN
- 13-1432060
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| J. Erik Fyrwald | Chief Executive Officer, Director | 120,966 |
| de Mendonca Ana Paula Teles | President, Scent | 0 |
| Marc Birenkrant | Controller & CAO | 9,643 |
| Michael DeVeau | EVP, CFO | 5,199 |
| Ralf Finzel | EVP, Global Operations Officer | 17,621 |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 37,925 |
| Yuvraj Arora | President, Taste & CCO | 17,283 |
| Andres Roberto Muller | President, Food Ingredients | 3,016 |
| Stephen N. Landsman | EVP, General Counsel | 17,164 |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 5,983 |
| Beril Yildiz | CAO, SVP & Controller | 3,321 |
| Angela Strzelecki | President, Pharma Solutions | 10,362 |
| Jennifer Amy Johnson | EVP, General Counsel | 7,357 |
| Simon Herriott | Pres. Health & Bioscience | 10,755 |
| Paul J. Fribourg | Director | 2,726,339 |
| Jesus B. Mantas | Director | – |
| Cynthia T. Jamison | Director | 604 |
| Dawn C. Willoughby | Director | 434 |
| Brett Icahn | Director | 34,712 |
| Virginia Drosos | Director | 2,434 |
| Mehmood Khan | Director | 7,173 |
| Richard Mulligan | Director | 1,712 |
| Kevin O'Byrne | Director | 26,071 |
| Mark J. Costa | Director | 463 |
| Hernandez Margarita Palau | Director | 2,393 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Mr Andreas Fibig | $0 | $0 | $4.36M | $71 | $110 |
| FY2025 Mr Erik Fyrwald | $15.00M | $7.49M | $4.36M | $71 | $110 |
| FY2025 Mr Frank Clyburn | $0 | $0 | $4.36M | $71 | $110 |
| FY2024 Mr Andreas Fibig | $0 | $0 | $3.59M | $75 | $126 |
| FY2024 Mr Erik Fyrwald | $24.15M | $25.11M | $3.59M | $75 | $126 |
| FY2024 Mr Frank Clyburn | $5.08M | $339.71K | $3.59M | $75 | $126 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had approximately 21,500 employees worldwide, of whom approximately 5,500 are employed in the United States.”
Corporate history
Events identified from SEC filings